Medically, you don’t have to taper off semaglutide, but many experts recommend it when stopping the medication. Some ...

Eli Lilly’s oral GLP-1 therapy, orforglipron, met all primary and key secondary endpoints in the Phase III ACHIEVE-2 and ACHIEVE-5 studies, showing significant A1C reduction, weight loss, and ...

Henry Meds is a subscription-based telehealth platform that focuses on treatment for endocrine-related conditions. Offerings ...

GLP-1–pathway agonists such as semaglutide and newer multi-agonists have transformed care for obesity and diabetes, yet developers still wrestle with durability, tissue targeting, and signal "bias." ...

A woman's abdominal discomfort turned out to be caused by a build up of food in her stomach. And the treatment involved diet soda.

KATIE Price has revealed that her son Harvey has lost 1.5 stone after starting fat jabs. She also revealed how he smashed ...

In a big win for local drug manufacturer Aspen Pharmacare, the South African Health Products Regulatory Authority (Sahpra) ...

Chemistry researchers at the University of Utah have uncovered an enzyme, dubbed PapB, that can "tie off" therapeutic ...

Viking is developing VK2735, its dual GIP/GLP-1 receptor agonist, in injectable form -- like current marketed weight ...

During menopause, women often deal with biological, physical, and emotional issues — to help them lose weight, clinicians ...

Chemistry researchers at the University of Utah have uncovered an enzyme, dubbed PapB, that can "tie off" therapeutic peptides—protein-like drugs—into ...

Chemistry researchers at the University of Utah have discovered an enzyme referred to as PapB, which is capable of "tying off ...